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Sepsis exemplifi  es a complex clinical syndrome 
characterized by a severe infection in the body 
and bloodstream that most commonly originates 
in the lung, urinary tract, and abdomen (1, 2). 
Although sepsis is generally associated with a 
high mortality, patients with septic peritonitis 
have a particularly high mortality rate of 60–80%. 
Septic peritonitis is characterized by massive in-
fi   ltration of neutrophils and macrophages into 
the peritoneum where these cells are the fi  rst line 
of defense for clearing invading microorganisms. 
However, once they fail to restrict microbes to 
the peritoneal cavity, microbes may reach the 
blood stream, resulting in an overwhelming sys-
temic immune response via production of proin-
fl  ammatory mediators such as cytokines (1, 2). 
Such mediators in turn appear to play a key role 
in the pathogenesis of septic shock or multiorgan 
failure after bacterial infections.
Recently, IL-27 has been identifi   ed as a 
new bioactive member of the IL-12 cytokine 
family (3). It consists of an IL-12 p40–related 
polypeptide, denoted EBV-induced gene 3 
(EBI3), and a novel p28 subunit with some 
similarities to IL-12 p35 and IL-23 p19, respec-
tively (3, 4). The IL-27 heterodimer mediates 
its biological function via binding to a specifi  c 
receptor on target cells consisting of the orphan 
receptor WSX-1/TCCR and the widely ex-
pressed gp130 protein (5). Over the last several 
years, IL-27 has emerged as a pivotal cytokine 
in the adaptive immune system by controlling 
T cell–dependent immune responses. Hereby, 
IL-27 activates STAT1 and STAT3 in naive 
CD4 T cells and NK cells. While STAT1 phos-
phorylation is required for IL-27–mediated ac-
tivation of the Th1 master transcription factor 
T-bet (6), STAT3 is considered to be impor-
tant for IL-27–induced T cell proliferation (7).
DCs and macrophages have been identifi  ed 
as rapid producers of IL-27 subunits after 
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Toll-like receptor (TLR) ligation (8), suggesting that IL-27 
may act very early in Th1-mediated immunity. However, 
recent studies demonstrated that the biological function of 
IL-27/WSX-1 signaling is more complex, as it is also criti-
cally involved in the negative control of both Th1 and Th2 
infl  ammatory responses (9–11). Finally, mice defi  cient for the 
EBI3 subunit of IL-27 showed reduced iNK T cell numbers 
and cytokine production, suggesting that EBI3 controls iNK 
T cell activity (12).
Because WSX-1 is highly expressed on naive T cells, 
IL-27–related research primarily concentrated on the biol-
ogy of T cells; however, WSX-1 and gp130 are also ex-
pressed on B cells, DCs, macrophages, and mast cells, 
suggesting that IL-27 function is not restricted to T cells. In 
fact, stimulation of human mast cells and blood monocytes 
with rIL-27 led to the activation of STAT transcription 
  factors and production of proinfl  ammatory cytokines (5). 
However, IL-27 signaling has also been implicated in 
STAT3-dependent negative regulation of murine mast cells 
and activated macrophages (9, 13).
Cytokines have been shown to be critically involved in 
both protective and pathogenic antimicrobial immune re-
sponses. As an imbalance in cytokine responses may result in 
persistent infections or destructive systemic infl  ammatory re-
sponse leading to multiorgan failure and death (1), a detailed 
understanding of local cytokine function during infections 
is of crucial importance for therapy of sepsis. However, the 
factors that determine the immune response during sepsis 
are still incompletely understood. Here, we demonstrate a 
crucial role of IL-27 in innate immunity and experimental 
septic peritonitis.
RESULTS AND DISCUSSION
Early local and systemic up-regulation of IL-27 expression 
after cecal ligation and puncture (CLP)
Septic peritonitis is characterized by an acute infl  ammatory 
response with a rapid production of cytokines. We and others 
have recently shown that microbial stimuli strongly induce 
IL-27 mRNA expression in vitro (3, 8), suggesting that this 
novel cytokine could be involved in the pathogenesis of sep-
tic peritonitis and shock. Therefore, we analyzed in an initial 
series of studies the expression of IL-27 in the murine CLP 
model of bacterial peritonitis. Accordingly, we analyzed the 
expression of the EBI3 and p28 subunits of IL-27 in organ 
lysates of septic animals and found that EBI3 and p28 mRNA 
levels in the lung and spleen were substantially increased 6 h 
after CLP, as determined by quantitative PCR (Fig. 1 A). 
  Interestingly, IL-27 EBI3 and p28 mRNA levels during CLP 
were up-regulated earlier and stronger than mRNA levels of 
IL-12 and IL-23 subunits, consistent with a potential role of 
IL-27 in innate immunity and the early pathogenesis of septic 
peritonitis. However, although EBI3 mRNA levels went 
back to almost normal levels 20 h after CLP, p28 mRNA 
levels still remained up-regulated. To confi   rm the data 
Figure 1.  Local and systemic accumulation of IL-27 protein in 
mice with septic peritonitis. 8-wk-old C57BL/6 mice (n = 5) were sub-
jected to sham or CLP surgery. (A) Organs were removed for total RNA 
isolation at the indicated time points, and quantitative real-time PCR was 
performed. Mean values are shown as fold induction relative to transcript 
levels in mice 6 h after sham surgery. (B) 6 or 20 h later, blood was col-
lected by cardiac puncture and peritoneal lavage fl  uid was obtained by 
washing the peritoneal cavity with 5 ml of sterile PBS. Samples were as-
sayed for IL-27 content by specifi  c sandwich ELISA. (C) Resident perito-
neal macrophages and elicited neutrophils were isolated as described in 
Materials and methods and stimulated for 20 h with 100 ng LPS. Super-
natants were assayed for IL-27 content by ELISA. One representative ex-
periment out of three is shown.JEM VOL. 203, August 7, 2006  1877
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  described above at the protein level, we performed IL-27–
specifi  c ELISA and detected a strong up-regulation of IL-27 
protein in the blood and peritoneal lavage fl  uid shortly after 
CLP (Fig. 1 B). In addition, experiments with resident peri-
toneal macrophages and elicited neutrophils demonstrated 
that these cells produce high amounts of IL-27 upon stimula-
tion with LPS in wild-type mice (Fig. 1 C), whereas such 
cells from TLR4 signaling–defi  cient C3H/Hej mice did not 
up-regulate IL-27 expression in response to LPS (macro-
phages: C3H, 122 pg/ml vs. C3H/Hej, 0 pg/ml; neutro-
phils: C3H, 87.6 pg/ml vs. C3H/Hej, 0 pg/ml). Thus, our 
data suggested that these cells are an important source of 
IL-27 upon TLR ligation in wild-type mice.
IL-27 EBI3 defi  ciency protects from sepsis-induced lethality
To determine the contribution of IL-27 to the mortality in 
sepsis after CLP, we performed studies in mice lacking the 
EBI3 subunit of IL-27. As shown in Fig. 2 A, survival rates in 
EBI3−/− mice were signifi  cantly higher than in the control 
group. Although all wild-type mice died within 4 d after 
CLP,  50% of the EBI3−/− mice survived for more than 
2 wk. In addition, i.p injection of 4 × 108 live Escherichia coli 
led to high lethality in wild-type mice, whereas all EBI3−/− 
mice survived (Fig. 2 B). These data suggested that IL-27 
EBI−/− mice are more resistant to lethality induced by 
  microbial infections.
Because IL-27 EBI3 defi  ciency was found to protect mice 
from CLP-associated lethality, we next examined whether 
administration of recombinant IL-27 would reverse this ef-
fect. Accordingly, we generated recombinant IL-27 (rIL-27) 
as specifi  ed below in Materials and methods. EBI3−/− mice 
were then subjected to CLP and injected i.p. with 10 μg rIL-27
or saline immediately after CLP. Treatment with rIL-27 
markedly increased mortality of IL-27 EBI3–defi  cient mice, 
Figure 2.  IL-27 EBI3−/− mice are resistant to sepsis-induced 
  lethality. The survival rates in EBI−/− and wild-type (EBI3+/+) mice were 
monitored for 14 d after CLP (15 mice per group) (A) or i.p. injection of 
4 × 108 live E. coli (10 mice per group) (B). The mortality rates were 
 signifi  cantly lower in the EBI3−/− group as compared with the wild-type 
littermates. (C) EBI3−/− mice were injected with recombinant scIL-27 
or saline immediately after CLP, and survival rates were monitored 
(eight mice per group). *, P < 0.05; **, P < 0.01.
Figure 3.  Increased leukocyte infi  ltration and local control of 
bacterial growth in IL-27 EBI3−/− mice. (A) 4 h after i.p. injection of 
1.5 ml of 3% thioglycollate (13 mice per group) or CLP (9 mice per group), 
the numbers of infi  ltrating leukocytes in the peritoneum were counted. 
Dilutions of blood or peritoneal lavage fl  uid obtained from EBI3+/+ or 
EBI3−/− mice 24 h after (B) CLP (6 mice per group) or (C) injection of 108 
E. coli (11–15 mice per group) were cultured on TSA blood agar plates, 
and the number of bacterial colonies was counted. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001.1878  IL-27 AS A NEGATIVE REGULATOR OF INNATE IMMUNE CELL FUNCTION | Wirtz et al.
suggesting that IL-27 plays an important regulatory role in 
septic peritonitis (Fig. 2 C).
Increased early leukocyte infl  ux and bacterial clearance 
in IL-27 EBI3−/− mice
In an initial attempt to explore the functional role of IL-27 in 
septic peritonitis, we next examined whether decreased mor-
tality in EBI3−/− mice is associated with changes in cell num-
bers of the peritoneal cavity. Therefore, we assessed the 
leukocyte infl  ux into the peritoneum after CLP and found 
that the granulocyte infi  ltration at 4 h was signifi  cantly aug-
mented in IL-27–defi  cient mice as compared with wild-type 
mice (Fig. 3 A). Similar results were obtained 4 h after i.p. 
challenge of wild-type and knockout mice with 1.5 ml of 3% 
thioglycollate (Fig. 3 A).
Because an early removal of bacteria is critical for the 
prevention of an overwhelming systemic immune response, 
we subsequently compared bacterial numbers in the serum 
and peritoneum of EBI3–/– mice and controls. Interestingly, 
EBI3−/− mice had signifi  cantly lower numbers of bacteria 
both in the blood and peritoneum than EBI3+/+ mice 24 h 
after CLP (Fig. 3 B) or i.p. administration of 2 × 108 live 
E. coli (Fig. 3 C). Collectively, these data indicated that EBI3–/– 
mice have a higher capacity to eliminate microbial infections 
and thus to suppress septic peritonitis.
IL-27 down-regulates protective innate immune responses 
of myeloid cells
It has been recently shown that a variety of immune cells be-
sides T and NK cells may express both IL-27 receptor chains 
(5). We thus evaluated whether murine macrophages and 
polymorphonuclear neutrophils express WSX-1. RT-PCR 
and Western blot analysis revealed that both cell types express 
WSX-1 (Fig. S1, available at http://www.jem.org/cgi/ 
content/full/jem.20060471/DC1) and thus can potentially 
respond to IL-27 stimulation.
Because the fi  ndings described above indicated that the 
improved survival of EBI3−/− mice was related to a more ef-
fective bacterial clearance and local control of infection, we 
next compared the bactericidal activity of leukocytes between 
EBI3−/− and EBI3+/+ mice by analyzing reactive oxygen in-
termediates (ROI). Mice were injected with 1.5 ml of 3% 
thioglycollate for 4 and 24 h to generate an infl  ammatory stim-
ulus, and their potency to produce ROI was determined using 
fl  ow cytometry. Interestingly, granulocytes from EBI3−/− mice 
displayed a markedly enhanced ability to produce ROI as 
compared with EBI3+/+ mice, suggesting that IL-27 nega-
tively regulates the biological functions of granulocytes (Fig. 4 A). 
To further verify the latter hypothesis, we next isolated elicited 
leukocytes from wild-type C57BL/6 mice and stimulated them 
for 12 h with LPS or LPS plus rIL-27. As shown in Fig. 4 B, 
Figure 4.  Increased granulocyte-mediated bacterial clearance in 
EBI3−/− mice. (A) Mice were injected i.p. for 4 or 20 h with 1.5 ml of 3% 
thioglycollate. Determination of ROI production by peripheral blood gran-
ulocytes was performed by counting the percentage of cells that convert 
nonfl  uorescent DHR into fl  uorescent rhodamine 123 using fl  ow cytometry. 
(B) Mice were i.p. injected with 1.5 ml of 3% thioglycollate, and 20 h later, 
infi  ltrating leukocytes were isolated from the peritoneum. 3 × 106 cells 
were left unstimulated or stimulated with 100 ng E. coli LPS, 20 ng/ml 
rIL-27 alone, or in combination for 12 h. ROI-expressing cells were deter-
mined by fl  ow cytometry. (C) Mice (fi  ve to eight mice/group) were sub-
jected to CLP surgery, and serum was collected at the indicated time 
points for cytokine multiplexing. Mean values ± SD are shown. *, P < 0.05.JEM VOL. 203, August 7, 2006  1879
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rIL-27 down-regulated LPS-induced activation and ROI pro-
duction of both granulocytes and monocytes/macrophages. 
However, rIL-27 alone had no eff  ect on ROI production, 
suggesting that this cytokine controls inducible ROI produc-
tion upon TLR ligation. In a subsequent series of studies, we 
determined systemic cytokine levels using bead multiplexing 
technology. Although no diff  erences in levels of IL-10, TNF, 
and IFN-γ were noted, levels of IL-1 and IL-6 were signifi  -
cantly reduced in EBI3−/− mice as compared with wild-type 
mice at 20 h after CLP, suggesting that the enhanced control 
of infection in EBI3-defi  cient mice results in lower produc-
tion of some proinfl  ammatory cytokines as compared with 
wild-type mice (Fig. 4 C).
A soluble IL-27 receptor fusion protein protects mice 
from CLP-induced mortality
Because EBI3−/− mice were protected from septic perito-
nitis, we fi  nally determined the potential benefi  cial eff  ects 
of neutralizing the biological function of IL-27 in vivo. As 
soluble gp130 protein does not interfere with IL-27 sig-
naling (14), we attempted to block the biologic activity of 
IL-27 by generating a soluble form of its high-affi   nity re-
ceptor WSX-1. Accordingly, we constructed a fusion pro-
tein of the extracellular part of WSX-1 with the Fc part 
of IgG and expressed the resulting designer fusion protein, 
denoted sIL- 27R, in CHO cells (Fig. 5 A). In vitro stud-
ies showed that sIL-27R was able to inhibit IL-27–induced 
proliferation of splenic CD4+ T cells (Fig. S2, available at 
http://www.jem.org/cgi/content/full/jem.20060471/DC1).
Subsequently, we induced septic peritonitis in C57BL/6 
mice by CLP followed by a single i.p treatment with the 
sIL-27R   fusion protein immediately or 2 h after surgery. 
The survival rates in sIL-27R–treated mice were higher 
than in the saline-treated control group (Fig. 5 B), showing 
that blockade of IL-27 is an eff  ective therapy for experi-
mental septic peritonitis.
IL-27: a novel key player in septic peritonitis
Early immune responses to bacterial infections are primarily 
mediated by neutrophils and macrophages (1, 15–17) ex-
pressing pattern recognition receptors that bind to specifi  c 
molecular structures of microorganisms. The triggering of 
pattern recognition receptors and TLR signaling then initiate 
the secretion of proinfl  ammatory mediators, which promote 
the elimination of infectious agents. However, excessive in-
fl  ammation in bacterial infections can lead to marked tissue 
damage and lethal septic shock (1, 2). Thus, the immune re-
sponse induced by neutrophils and macrophages during bac-
terial infections needs to be tightly controlled. Here, we have 
identifi  ed the cytokine IL-27 as a novel regulator that con-
trols the magnitude of the innate immune reaction during 
experimental septic peritonitis. These fi  ndings may also at 
least partially explain the antiinfl  ammatory eff  ects of IL-27/
WSX-1 signaling observed in various parasitic infections, e.g. 
Toxoplasma gondii and Leishmania donovani (10, 18). Thus, in 
addition to negative regulatory functions of IL-27 on T lym-
phocytes (11), IL-27 exerts profound eff  ects on the activation 
of myeloid cells during infections.
Figure 5.  Protection from lethal septic shock by neutralizing the 
biological function of IL-27. (A) Graphical illustration of the recombi-
nant soluble IL-27 receptor fusion protein expressed in CHO cells. 
(B) C57BL/6 mice were subjected to CLP (fi  ve to nine mice/group). Directly 
(left) or 2 h (right) after CLP, mice were administered 1 mg sIL-27R fusion 
protein or saline into the peritoneal cavity. The survival rates were moni-
tored over time after CLP, as indicated.1880  IL-27 AS A NEGATIVE REGULATOR OF INNATE IMMUNE CELL FUNCTION | Wirtz et al.
The regulation of neutrophil functions during septic 
  peritonitis is still incompletely understood. However, C5a/
C5aR and TREM signaling have been recently identifi  ed as 
important modulators of the biological function of these cells 
(19–22). Here, we found that IL-27 subunits were rapidly 
produced by both macrophages and neutrophils during septic 
peritonitis. This rapid production is presumably due to aug-
mented EBI3 and p28 gene transcription, as both promoters 
contain TLR-responsive NF-κB binding elements (8).
Our data suggest a novel key role of IL-27 in regulating 
innate immunity and neutrophil function during septic perito-
nitis. Specifi  cally, IL-27 modulates neutrophil infl  ux/activa-
tion by an as yet unknown mechanism that presumably 
involves modulation of chemokines. Consistently, we recently 
found that IL-27 suppresses production of various chemokines 
in myeloid cells such as RANTES and I-TAC that control 
migration of immune cells (unpublished data). Furthermore, 
we identifi  ed IL-27 as a key negative regulator of oxidative 
burst by neutrophils. The clinical relevance of these observa-
tions was underlined in two models of experimental  peritonitis. 
First, we observed that EBI3−/− mice were protected from 
experimental septic peritonitis, and injection of recombinant 
IL-27 prevented such protection. Second, we found that 
EBI3−/− mice have signifi  cantly reduced mortality upon i.p. 
injection of live E. coli. In both models, IL-27 EBI3−/− mice 
had signifi  cantly reduced numbers of bacteria in the perito-
neum and blood associated with an increased oxidative burst 
capacity of neutrophils. The fact that neutrophils produce a 
cytokine such as IL-27 that inhibits their infl  ux/activation 
may represent an autoregulatory loop to limit neutrophil re-
sponses, or, more likely, may indicate that IL-27 has additional 
positive functional roles that remain to be elucidated.
Collectively, our data suggest a major role of IL-27 in 
modulating infl   ux and oxidative burst of granulocytes and 
elimination of bacteria during peritonitis. Thus, early IL-27 
production by myeloid cells may exert a negative feedback 
mechanism that limits protective innate immune responses in 
peritonitis. The therapeutic implication of these observations 
was fi  nally highlighted by the fi  nding that blockade of IL-27 
function using a newly designed sIL-27R fusion protein sup-
pressed experimental septic peritonitis and reduced mortality 
in vivo. Thus, our data provide novel insights into the cyto-
kine-driven regulation of neutrophil function during sepsis. 
Furthermore, blockade of IL-27 function by sIL-27R could be 
a novel treatment modality for patients with septic peritonitis.
MATERIALS AND METHODS
Animals and sepsis models. C57BL/6 mice were obtained from Charles 
River Laboratories. EBI3−/− mice have been described previously (12). 
  Animals were bred and maintained under specifi  c pathogen-free conditions in 
our animal facility. All experiments involving animals were performed under 
protocols approved by the Animal Ethics and Experimentation Committee 
of The Johannes Gutenberg University of Mainz. For CLP, mice were anes-
thetized by i.p injection of ketamin/xylazin. A 1-cm abdominal midline in-
cision was made, and the exposed cecum was ligated with a 5–0 silk suture 
below the ileocecal valve and punctured with an 18-gauge needle. Mice 
subjected to sham CLP underwent the same procedure, except for ligation 
and puncture of the cecum. In an additional series of experiments, mice were 
injected i.p. with live E. coli K12. For survival analysis, mice were monitored 
twice daily for 14 d.
Measurement of cytokines. For measurement of cytokines in peritoneal 
lavage fl  uid or serum/plasma, we used the mouse FlowCytomix kit (Bender 
Medsystems) according to the manufacturer’s instructions using a FACS-
Calibur System (Becton Dickinson). IL-27 levels were determined by sand-
wich ELISA (R&D Systems).
Determination of CFUs. Serial dilutions of peripheral blood or peritoneal 
lavage fl  uid of CLP-treated or E. coli–injected mice were plated on Caso blood 
agar plates (Heipha) at 37°C. CFUs were determined after 24 h.
Determination of leukocyte oxidative burst activity. Intracellular re-
spiratory burst activity was measured separately in monocytes and neutro-
phils using the Phagoburst kit (Orpegen) according to the manufacturer’s 
instructions. In brief, 100 μl of heparinized peripheral blood was mixed with 
20 μl of a substrate solution containing nonfl  uorescent dihydrorhodamine 
123 (DHR) and incubated for 10 min at 37°C. Oxidation of DHR to the 
green fl  uorescent rhodamine 123 was used as an indicator of respiratory 
burst. The percentage of ROI-producing cells was counted in a fl  ow cytom-
eter (FACSCalibur; Becton Dickinson). To discriminate monocytes and 
granulocytes, gates were set by a linear FCS/SSC analysis.
Isolation of resident macrophages and elicited neutrophils. For isola-
tion of resident macrophages, mice were injected with 5 ml PBS. Macro-
phages were isolated from peritoneal lavage by plastic adherence. For 
isolation of granulocytes, mice were injected i.p. with 1.5 ml sterile thiogly-
collate (3%). Elicited cells were harvested 4 h later by peritoneal lavage with 
5 ml of cold PBS. In some experiments, neutrophils were further purifi  ed 
from peritoneal lavage by magnetic cell sorting. In brief, cells were labeled 
with an FITC-conjugated anti-neutrophil antibody (Caltag) and sorted to 
a purity of >95% with the FITC multisort kit (Miltenyi Biotec).
Quantitative analysis of gene expression. Total cellular RNA was ex-
tracted from cells and organs with RNeasy columns (QIAGEN), including 
DNase I digestion. Quantitative real-time PCR analysis for IL-27 EBI3 and 
p28, IL-12 p35, IL-23 p19, IL-12/IL-23 p40, and HPRT was performed 
using specifi  c Quantitect Primer/Probe assays (QIAGEN).
scIL-27 and sIL-27R. For construction of bioactive murine IL-27, the 
cDNAs encoding for EBI3 and p28 were cloned from LPS-stimulated spleno-
cytes by reverse transcriptase PCR. For cloning of single-chain IL-27 (scIL-27), 
fragments encoding the EBI3 part, followed by a Val4Gly4Pro2 linker and the 
mature coding sequence of p28, were generated by PCR and cloned into 
the p3XFlag expression vector (Sigma-Aldrich). To ensure effi   cient secre-
tion, the EBI3 leader sequence was replaced by the signal peptide of IgGκ.
The cDNA coding for a soluble WSX fusion protein was generated by liga-
tion of the extracellular portion of WSX-1 to the Fc part of IgG2a. The extra-
cellular part of WSX-1 was cloned into pCDNA3.1TOPO expression vector by 
PCR using PfuUltra (Stratagene) and a primer introducing a factor Xa cleaving 
site followed by an XhoI site (pcDNA3.1-sWSX). The Fc part of IgG2a was 
amplifi  ed from cDNA of the OKT3 hybridoma and cloned into the XhoI-cut 
pcDNA3.1-sWSX vector. For protein expression, CHO cells were transfected 
with 5 μg of linearized plasmid DNA and stable transfectants were isolated by 
  selection with 1 mg/ml G418. Culture supernatants of stable transfectants were 
harvested, and the fusion protein was purifi  ed from the supernatant with Fast-
fl  ow protein G columns  (GE Healthcare).
Statistical analysis. Data are expressed as mean values ± standard deviations. 
Statistical analysis was performed using the unpaired Student’s t test or with a 
log rank test for survival analysis (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
Online supplemental material. Fig. S1 shows the expression of the IL-27 
receptor on mouse-resident peritoneal macrophages and elicited   neutrophils. JEM VOL. 203, August 7, 2006  1881
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Fig. S2 shows the specifi  c down-regulation of IL-27–induced proliferation 
of T cells by sIL-27R. Fig. S3 shows a comparison of HMGB1 expression 
in septic EBI3−/− and EBI3+/+ mice. Figs. S1–S3 are available at http://
www.jem.org/cgi/content/full/jem.20060471/DC1.
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